Morningstar Investment Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,617
Closed -$3.17M 284
2024
Q3
$3.17M Buy
3,617
+634
+21% +$570K 0.03% 158
2024
Q2
$2.71M Buy
2,983
+667
+29% +$534K 0.03% 154
2024
Q1
$1.8M Sell
2,316
-851
-27% -$606K 0.02% 166
2023
Q4
$1.84M Buy
3,167
+1,426
+82% +$832K 0.01% 191
2023
Q3
$948K Buy
1,741
+923
+113% +$476K 0.01% 179
2023
Q2
$379K Buy
+818
New +$343K ﹤0.01% 205
2016
Q4
Sell
-15,502
Closed -$1.24M 201
2016
Q3
$1.24M Sell
15,502
-1,275
-8% -$102K 0.04% 156
2016
Q2
$1.32M Buy
+16,777
New +$1.26M 0.04% 155
2014
Q1
Sell
-32,836
Closed -$1.68M 209
2013
Q4
$1.68M Buy
+32,836
New +$1.64M 0.13% 130

Other funds holding LLY

Morningstar Investment Services's LLY Position: Q4 2024 in Review

Morningstar Investment Services sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 3,617 shares — an estimated $3.17M sold.

Morningstar Investment Services first reported a position in LLY in Q4 2013 and held it in 9 quarters. The position peaked at $3.17M in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Morningstar Investment Services reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Morningstar Investment Services sold 3,617 Eli Lilly shares in Q4 2024, an estimated $3.17M.
  • Morningstar Investment Services first reported a position in Eli Lilly in Q4 2013 and held it in 9 quarters.
  • Morningstar Investment Services's Eli Lilly position peaked at $3.17M in Q3 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Morningstar Investment Services's 13F filing for Q4 2024, filed 12 Feb 2025.